Baker Brothers Life Sciences Capital (GP), LLC

Average Profitability
155.53%
Insider Buys Quantity
54
Insider Buys Sum
$114.37M
Insider Sells Quantity
8
Insider Sells Sum
$22.96M

Insider Activity of Baker Brothers Life Sciences Capital (GP), LLC

The largest purchase of all time was on 2011-12-05 and amounted to 1071825 shares of Incyte Corporation for $14.88M.

The largest sale of all time was on 2010-09-21 and amounted to 610072 shares of Incyte Corporation for $9.12M.

Biography of Baker Brothers Life Sciences Capital (GP), LLC

No biography is available at this moment.

2012-01-13PurchaseIncyte Corporation
INCY
director, 10 percent owner
217,511
0.1675%
$16.53$3.6M+7.94%
2012-01-12PurchaseIncyte Corporation
INCY
director, 10 percent owner
325,728
0.2536%
$16.26$5.3M+10.87%
2011-12-09PurchaseIncyte Corporation
INCY
director, 10 percent owner
181,201
0.1389%
$13.26$2.4M+33.6%
2011-12-08PurchaseIncyte Corporation
INCY
director, 10 percent owner
222,320
0.1755%
$13.46$2.99M+35.6%
2011-12-07PurchaseIncyte Corporation
INCY
director, 10 percent owner
144,903
0.1132%
$13.22$1.92M+36.62%
2011-12-06PurchaseIncyte Corporation
INCY
director, 10 percent owner
338,406
0.2666%
$13.53$4.58M+34.59%
2011-12-05PurchaseIncyte Corporation
INCY
director, 10 percent owner
1.07M
0.8381%
$13.89$14.88M+30.16%
2011-12-01PurchaseIncyte Corporation
INCY
director, 10 percent owner
828,622
0.6369%
$14.12$11.7M+25.83%
2011-11-30PurchaseIncyte Corporation
INCY
director, 10 percent owner
507,911
0.3898%
$13.44$6.83M+31.95%
2011-11-29PurchaseIncyte Corporation
INCY
director, 10 percent owner
1.07M
0.8309%
$12.21$13.06M+47.01%
2010-09-23SaleIncyte Corporation
INCY
director, 10 percent owner
179,644
0.147%
$14.86$2.67M+8.14%
2010-09-22SaleIncyte Corporation
INCY
director, 10 percent owner
227,071
0.1882%
$14.71$3.34M+10.6%
2010-09-21SaleIncyte Corporation
INCY
director, 10 percent owner
610,072
0.5007%
$14.94$9.12M+7.85%
2010-08-10SaleIncyte Corporation
INCY
director, 10 percent owner
88,250
0.0739%
$14.00$1.24M+17.32%
2010-08-09SaleIncyte Corporation
INCY
director, 10 percent owner
313,622
0.2556%
$14.08$4.42M+13.51%
2009-06-01SaleBioCryst Pharmaceuticals, Inc.
BCRX
10 percent owner
153,371
0.4032%
$3.87$593,536+93.77%
2009-05-29SaleBioCryst Pharmaceuticals, Inc.
BCRX
10 percent owner
126,448
0.3416%
$4.15$524,991+85.57%
2009-05-28SaleBioCryst Pharmaceuticals, Inc.
BCRX
10 percent owner
237,113
0.65%
$4.49$1.06M+74.07%
2009-03-05PurchaseIncyte Corporation
INCY
director, 10 percent owner
11,232
0.0116%
$2.16$24,233+190.47%
2009-03-03PurchaseIncyte Corporation
INCY
director, 10 percent owner
9,524
0.0094%
$2.14$20,397+177.7%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.